title: 3Rs of animal testing for regenerative medicine products.
abstract: Considerations of animal welfare have spurred the design of "smarter" preclinical studies intended to ultimately benefit patients.
authors.affiliation: Commissioner's Fellowship Program, Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. rebecca.robinson@fda.hhs.gov
authors.forename: Rebecca
authors.initials: R
authors.lastname: Robinson
mesh_terms: D000827:Animal Welfare; D000818:Animals; D044968:Regenerative Medicine; D014481:United States; D014486:United States Food and Drug Administration